Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0011860 (
type 2 diabetes
)
57,723
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A 70-year-old man with a 28-year history of
type 2 diabetes
mellitus was admitted due to persistent vomiting and neurological abnormalities in Nov 2012. He had developed gait disturbance and diplopia for six months during antiplatelet therapy, which was initiated following the diagnosis of a cerebellar infarction in June 2012. He had nystagmus, truncal ataxia and an ocular motility disorder, and the MRI study showed increased FLAIR and DWI signals in the peri-third ventricle and periaqueductal region, in addition to the cerebellar vermis.
Wernicke encephalopathy
was suspected according to his symptoms, and thiamine administration dramatically improved his condition. He did not have a history of alcohol abuse or poor eating habits; however, various coexisting factors, including diabetes mellitus, pyloric stenosis and the use of antiulcer drugs and insulin, were considered to be responsible for
Wernicke encephalopathy
. This case demonstrates the importance of distinguishing
Wernicke encephalopathy
from cerebrovascular disease in elderly patients.
...
PMID:[A Case of an Elderly Diabetic Patient Developing Wernicke Encephalopathy without Alcohol Abuse or an Unbalanced Diet]. 2599 90
Objective:
The development of these updated clinical practice guidelines (CPGs) was commissioned by the American Association of Clinical Endocrinologists (AACE), The Obesity Society, American Society of Metabolic and Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists Boards of Directors in adherence with the AACE 2017 protocol for standardized production of CPGs, algorithms, and checklists.
Methods:
Each recommendation was evaluated and updated based on new evidence from 2013 to the present and subjective factors provided by experts.
Results:
New or updated topics in this CPG include: contextualization in an adiposity-based chronic disease complications-centric model, nuance-based and algorithm/checklist-assisted clinical decision-making about procedure selection, novel bariatric procedures, enhanced recovery after bariatric surgery protocols, and logistical concerns (including cost factors) in the current health-care arena. There are 85 numbered recommendations that have updated supporting evidence, of which 61 are revised and 12 are new. Noting that there can be multiple recommendation statements within a single numbered recommendation, there are 31 (13%) Grade A, 42 (17%) Grade B, 72 (29%) Grade C, and 101 (41%) Grade D recommendations. There are 858 citations, of which 81 (9.4%) are evidence level (EL) 1 (highest), 562 (65.5%) are EL 2, 72 (8.4%) are EL 3, and 143 (16.7%) are EL 4 (lowest).
Conclusion:
Bariatric procedures remain a safe and effective intervention for higher-risk patients with obesity. Clinical decision-making should be evidence based within the context of a chronic disease. A team approach to perioperative care is mandatory, with special attention to nutritional and metabolic issues.
A1C
= hemoglobin A1c;
AACE
= American Association of Clinical Endocrinologists;
ABCD
= adiposity-based chronic disease;
ACE
= American College of Endocrinology;
ADA
= American Diabetes Association;
AHI
= Apnea-Hypopnea Index;
ASA
= American Society of Anesthesiologists;
ASMBS
= American Society of Metabolic and Bariatric Surgery;
BMI
= body mass index;
BPD
= biliopancreatic diversion;
BPD/DS
= biliopancreatic diversion with duodenal switch;
CI
= confidence interval;
CPAP
= continuous positive airway pressure;
CPG
= clinical practice guideline;
CRP
= C-reactive protein;
CT
= computed tomography;
CVD
= cardiovascular disease;
DBCD
= dysglycemia-based chronic disease;
DS
= duodenal switch;
DVT
= deep venous thrombosis;
DXA
= dual-energy X-ray absorptiometry;
EFA
= essential fatty acid;
EL
= evidence level;
EN
= enteral nutrition;
ERABS
= enhanced recovery after bariatric surgery;
FDA
= U.S. Food and Drug Administration;
G4G
= Guidelines for Guidelines;
GERD
= gastroesophageal reflux disease;
GI
= gastrointestinal;
HCP
= health-care professional(s);
HTN
= hypertension;
ICU
= intensive care unit;
IGB
= intragastric balloon(s);
IV
= intravenous;
LAGB
= laparoscopic adjustable gastric band;
LAGBP
= laparoscopic adjustable gastric banded plication;
LGP
= laparoscopic greater curvature (gastric) plication;
LRYGB
= laparoscopic Roux-en-Y gastric bypass;
LSG
= laparoscopic sleeve gastrectomy;
MetS
= metabolic syndrome;
NAFLD
= nonalcoholic fatty liver disease;
NASH
= nonalcoholic steatohepatitis;
NSAID
= nonsteroidal anti-inflammatory drug;
OA
= osteoarthritis;
OAGB
= one-anastomosis gastric bypass;
OMA
= Obesity Medicine Association;
OR
= odds ratio;
ORC
= obesity-related complication(s);
OSA
= obstructive sleep apnea;
PE
= pulmonary embolism;
PN
= parenteral nutrition;
PRM
= pulmonary recruitment maneuver;
RCT
= randomized controlled trial;
RD
= registered dietician;
RDA
= recommended daily allowance;
RYGB
= Roux-en-Y gastric bypass;
SG
= sleeve gastrectomy;
SIBO
= small intestinal bacterial overgrowth;
TOS
= The Obesity Society;
TSH
= thyroid-stimulating hormone;
T1D
= type 1 diabetes;
T2D
=
type 2 diabetes
;
VTE
= venous thromboembolism;
WE
=
Wernicke encephalopathy
;
WHO
= World Health Organization.
...
PMID:CLINICAL PRACTICE GUIDELINES FOR THE PERIOPERATIVE NUTRITION, METABOLIC, AND NONSURGICAL SUPPORT OF PATIENTS UNDERGOING BARIATRIC PROCEDURES - 2019 UPDATE: COSPONSORED BY AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY, THE OBESITY SOCIETY, AMERICAN SOCIETY FOR METABOLIC & BARIATRIC SURGERY, OBESITY MEDICINE ASSOCIATION, AND AMERICAN SOCIETY OF ANESTHESIOLOGISTS -
EXECUTIVE SUMMARY
. 3168 18